Jaguar Health, Inc.
JAGX
$1.02
-$0.14-12.07%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -0.80% | 9.48% | -5.83% | 52.57% | 10.49% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.80% | 9.48% | -5.83% | 52.57% | 10.49% |
| Cost of Revenue | -1.66% | 23.42% | 19.77% | -18.92% | 5.25% |
| Gross Profit | -0.62% | 6.89% | -11.56% | 83.01% | 11.66% |
| SG&A Expenses | 5.96% | 23.23% | 26.89% | 23.22% | 15.60% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.47% | 10.77% | 10.12% | 22.98% | -10.60% |
| Operating Income | 0.33% | -11.25% | -14.68% | -13.51% | 17.36% |
| Income Before Tax | 3.72% | -9.68% | -13.11% | -9.94% | -26.78% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 3.72% | -9.68% | -13.11% | -9.94% | -26.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -12.57% | 12.50% | -7.04% | 125.90% | 32.54% |
| Net Income | 3.57% | -9.64% | -13.42% | -8.18% | -26.69% |
| EBIT | 0.33% | -11.25% | -14.68% | -13.51% | 17.36% |
| EBITDA | 0.43% | -11.54% | -15.92% | -14.89% | 18.05% |
| EPS Basic | 76.12% | -286.03% | 80.83% | 92.60% | 95.33% |
| Normalized Basic EPS | 76.09% | -217.78% | 83.10% | 92.36% | 96.84% |
| EPS Diluted | 76.12% | -286.03% | 80.83% | 92.60% | 95.33% |
| Normalized Diluted EPS | 76.09% | -217.78% | 83.10% | 92.36% | 96.84% |
| Average Basic Shares Outstanding | 303.74% | -71.60% | 491.69% | 1,361.04% | 2,615.94% |
| Average Diluted Shares Outstanding | 303.74% | -71.60% | 491.69% | 1,361.04% | 2,615.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |